The latest shipment of 1.1 million COVID-19 vaccines to Rwanda signaled a noteworthy achievement: The COVAX program, a United Nations-backed program providing poorer countries with vaccines.
Concise drug information for molnupiravir and Paxlovid; the FDA granted Emergency Use to both oral antiviral therapies.
In a Canadian employer screening program, the overall rate of false-positive results using rapid antigen test screens for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is very low.
The incidence of COVID-19 is increased in association with long-term exposure to airborne pollutants.
Researchers conducted a study to determine the safety and efficacy of the Ad5-nCoV vaccine for protection against SARS-CoV-2 infection in adult patients.
Private insurers will have to cover the cost of 8 at-home COVID-19 tests per person per month.
Scottish researchers tested the accuracy of the QCovid algorithm, a risk prediction tool developed in the UK for predicting adverse COVID-19 outcomes.
Researchers investigated the cause of dyspnea in individuals with long-haul COVID and also screened the patients for myalgic encephalomyelitis/chronic fatigue syndrome.
Read writer Diane Eastabrook’s compelling series of articles describing how loneliness and isolation are affecting seniors living at home.
National health care spending in 2020 increased 9.7% in the United States.